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ABSTRACT
Introduction: Chronic non-communicable diseases
(NCDs) account for a high burden of mortality and
morbidity in Africa. Evidence-based clinical guidelines
recommend exercise training and promotion of
physical activity behaviour changes to control NCDs.
Developing such interventions in Africa requires an
understanding of the essential components that make
them effective in this context. This is a protocol for a
systematic mixed studies review that aims to determine
the effective components of exercise and physical
activity-related behaviour-change interventions for
chronic diseases in Africa, by combining quantitative
and qualitative research evidence from studies
published until July 2015.
Methods and analysis: We will conduct a detailed
search to identify all published and unpublished
studies that assessed the effects of exercise and
physical activity-related interventions or the
experiences/perspectives of patients to these
interventions for NCDs from bibliographic databases
and the grey literature. Bibliographic databases include
MEDLINE, EMBASE, CENTRAL (Cochrane Central
Register of Controlled Trials), PsycINFO, CINAHL and
Web of Science. We will include the following African
regional databases: African Index Medicus (AIM) and
AFROLIB, which is the WHO’s regional office database
for Africa. The databases will be searched from
inception until 18 July 2015. Appraisal of study quality
will be performed after results synthesis. Data
synthesis will be performed independently for
quantitative and qualitative data using a mixed methods
sequential explanatory synthesis for systematic mixed
studies reviews. Meta-analysis will be conducted for
the quantitative studies, and thematic synthesis for
qualitative studies and qualitative results from the non-
controlled observational studies. The primary outcome
will include exercise adherence and physical activity
behaviour changes. This review protocol is reported
according to Preferred Reporting Items for Systematic
reviews and Meta-Analysis protocols (PRISMA-P) 2015
guidelines.
Ethics and dissemination: There is no ethical
requirement for this study, as it utilises published data.
This review is expected to inform the development of
exercise and physical activity-related behaviour-change
interventions in Africa, and will be presented at
conferences, and published in peer reviewed journals
and a PhD thesis at King’s College London.
Protocol registration number: This study was
registered with the International Prospective Register of
Systematic Reviews (PROSPERO) on 22 January 2015
(registration number: PROSPERO 2015:
CRD42015016084).
INTRODUCTION
Rationale
Eighty per cent of worldwide deaths from
chronic non-communicable diseases (NCDs)
occur in low and middle-income countries,
of which 80% occurred in only 23 countries.1
Nigeria, South Africa, Egypt, Congo and
Ethiopia were the African countries among
these. The main chronic NCDs in African
countries include cardiovascular diseases,
diabetes, cancer and chronic respiratory
disease.2 Bone and joint disorders also con-
tribute signiﬁcantly to the burden of chronic
conditions in the region.3 There have been
reports of an interrelation between common
NCDs and bone and joint disorders.4 For
instance, according to the Centres for
Disease Control and Prevention,5 obesity is a
common risk factor for the aforementioned
chronic conditions. Furthermore, obesity and
chronic pain are believed to have a multifac-
torial link with no single identiﬁable causa-
tive relationship between the two.4 Obesity
and chronic pain may arise due to genetic,
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metabolic and psychological factors.6 7 Obesity is
hypothesised to cause pain due to increased mechanical
loading while chronic pain may lead to obesity as a
result of physical inactivity and increased eating,4 further
increasing the risk for chronic diseases.
Behaviour-change interventions for chronic conditions
often target change in behaviour,8 deﬁned as coordi-
nated sets of activities designed to change particular
behaviour patterns.9 10 A signiﬁcant component of
behaviour change interventions may be non-
pharmacological,11 12 with exercises to increase physical
activity being of utmost importance.13 Evidence-based
clinical practice guidelines for the treatment of NCDs
recommend exercise training to promote physical activ-
ity.14–18 This is known to improve physiological function-
ing, cognitive, emotional, social and psychosocial
functioning as well as to alter health beliefs and increase
acceptance of chronic disease.13 Furthermore, systematic
reviews and meta-analysis of randomised controlled trials
(RCTs) suggest that exercises promoting physical activity
may be effective in reducing disability and improving
chronic pain.19–24
The challenges presented by chronic diseases in
Africa may undermine the development of effective and
sustainable primary and secondary interventions.25
Evidence suggests that implementing such non-
pharmacological interventions may be difﬁcult in Africa,
due to the predominant biomedical model of practice
within an acute infective healthcare model.26 Results
from a qualitative study that explored treatment adher-
ence among patients with diabetes, hypertension, or
both, in a South African community, suggest that factors
that may inﬂuence adherence to behaviour-change
interventions may be multifactorial, including the attri-
bution of the origin of the illness, experiences with the
public healthcare system, concerns about the conse-
quences of poor adherence, ﬁnancial problems, trans-
port problems and social support.27 The intervention in
the study, however, was predominantly pharmacological.
A recent qualitative exploration of non-speciﬁc chronic
low back pain in rural Nigeria suggests that patients may
view non-pharmacological interventions as illegitimate
treatment possibly inﬂuenced by the predominant acute
infective model of healthcare.28 This suggests that poor
treatment adherence may be more pronounced, with
interventions having little or no pharmacological com-
ponent. Therefore, developing potentially effective exer-
cise and physical activity-related behaviour-change
interventions for chronic non-communicable conditions
in Africa requires an understanding of the components
that may increase patients’ adherence to these interven-
tions and make them effective in this context. This is
especially relevant, as exercise programmes that
promote adherence to behaviour change may be under-
pinned by theories that may be informed by contextual
factors irrespective of the chronic condition.13 This sys-
tematic review aims to determine the effective compo-
nents of exercise and physical activity-related
behaviour-change interventions for chronic NCDs in
Africa, by combining quantitative and qualitative
research evidence. This protocol for a systematic mixed
studies review with meta-analysis is reported according to
the Preferred Reporting Items for Systematic reviews
and Meta-Analyses Protocol (PRISMA-P) 2015
guidelines.29 30
Objectives
To conduct a systematic mixed studies review and
meta-analysis, to determine the effective components of
exercise and physical activity-related behaviour-change
interventions for chronic NCDs in Africa, by combining
qualitative and quantitative research evidence.
Review questions
The current review will seek to address the following
main research question:
What are the effective components of exercise and
physical activity-related behaviour-change interventions
for common chronic NCDs in adult Africans, based on
reports from studies published from inception of data-
bases to July 2015?
To answer the above objective, secondary research
questions to be addressed include:
1. What is the effectiveness of exercise and physical
activity-related behaviour-change interventions for
managing common chronic NCDs in Africa?
2. What are the experiences and perspectives of adult
African patients on exercise and physical
activity-related behaviour-change interventions for
managing common chronic NCDs?
METHODS
A two stage review will be carried out. Studies meeting
the listed broad eligibility criteria will be described.
Finally, the studies that meet the narrower focus on
adherence to the exercise and physical activity-related
interventions will be further reviewed.
Eligibility criteria
Eligibility criteria to be considered for selecting studies
in the review include:
Inclusion criteria
1. Language: There will be no language restriction.
2. Participants: We will include studies investigating
adult African patients (≥18 years) diagnosed with
chronic NCDs in Africa. Studies in people of African
ancestry not residing in Africa will not be included.
The targeted chronic diseases will include chronic
pain (musculoskeletal pain including degenerative
conditions such as osteoarthritis or osteoporosis
affecting the back, hip, knee, ankle, shoulder, elbow,
wrist, neck; ﬁbromyalgia and chronic fatigue syn-
drome), hypertension, diabetes or obesity, using
standard diagnostic criteria. Chronic pain will be
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considered any pain that has duration of at least
3 months. We will use WHO’s deﬁnitions of the
named chronic NCDs.
3. Interventions: Exercise and physical activity-related
behaviour-change interventions for patients with
chronic diseases in Africa. As many such interven-
tions may be complex, comprising of several compo-
nents, interventions in addition to exercises and
physical activity, including medications, nutrition,
health education, psychological interventions, social
interventions, psychosocial or any form of patient
support, will also be included. Interventions might
involve contact of patients with lay individual(s) or
peer groups, and/or health professional(s) or alter-
native practitioners. Contact might be face-to-face,
telephone-based or web-based.
4. Study settings: Health centres, clinics, hospitals or
community settings in rural or urban Africa.
5. Study designs: RCTs and non-RCTs (quasi-RCTs, con-
trolled clinical trials (cross-over trials), controlled
before and after trials and non-controlled before and
after studies) that evaluated the effects of these inter-
ventions will be included. Observational studies that
evaluated the effects of these interventions; or evalu-
ated the factors that inﬂuence adherence to the
interventions; or explored the factors that inﬂuence
the effectiveness of the interventions, will be
included. Qualitative studies that evaluated experi-
ences or perspectives of patients to these interven-
tions will be included.
6. Comparators/control: Any type of control will be
included. Intervention studies without control groups
will also be included.
7. Timing: There will be no restriction based on the
length of the administration of the interventions or
the follow-up of outcomes.
8. Outcomes: The primary outcome will include attend-
ance rate for the exercise and physical activity-related
interventions where there was no follow-up period
postintervention; or the rate of exercise adherence
and physical activity behaviour changes postinterven-
tion where there was a follow-up period postinterven-
tion. Secondary outcomes will include other clinical
outcomes such as disability/physical function, pain
and change in blood pressure, body mass index and
blood sugar. Psychological outcomes will assess
factors such as self-efﬁcacy, and change in knowledge,
attitudes, quality of life, conﬁdence, self-esteem, well-
being, vitality, social functioning and coping. When
clinical outcomes are reported by individual studies,
these will be analysed and graded. If a given clinical
outcome is not reported on, we will analyse and
grade the closest surrogate outcome, if available. All
outcomes will be collected as they are reported in
individual studies including dichotomous or continu-
ous outcomes. Quality of life measures will be col-
lected only if they are measured with generic
validated tools. We will extract deﬁnitions of
outcomes as they are reported in the included
studies due to the possible changes in disease deﬁni-
tions over time.
Exclusion criteria
1. Studies without an exercise or physical activity
component.
2. Narrative reviews, systematic reviews, opinion papers,
letters and any publication without primary data
and/or explicit description of the methods.
3. Duplicate publications from the same study. For
those studies published in more than one journal/
conference, the most comprehensive and recent
report will be used.
Information sources
Search strategy for identifying relevant studies will com-
prise two stages including the search of bibliographic
databases and the grey literature; and the selection of
studies for inclusion. The search strategy was developed
and pilot-tested in collaboration with two health infor-
mation specialists (librarians), at King’s College London,
with several years of experience in systematic reviews,
not associated with the study.
Identifying research evidence through bibliographic
databases
1. Studies will be identiﬁed using a predeﬁned compre-
hensive and sensitive strategy (see online supplemen-
tary appendix) to search bibliographic databases
including MEDLINE (OvidSP, 1946 onwards),
EMBASE (OvidSP, 1980 onwards), PsycINFO (OvidSP,
1806 onwards), CENTRAL (Cochrane Central
Register of Controlled Trials, current issue), CINAHL
(EBSCO) and ISI Web of Science (Science Citation
Index, 1900 onwards) until 18 July 2015. We will
search the following African regional databases:
African Index Medicus (AIM) and AFROLIB, which
is the WHO’s regional ofﬁce database for Africa,
until 18 July 2015. The search strategy will be
informed by the African search ﬁlter, reported to
have good sensitivity (74% for Medline and 73% for
EMBASE), and improved precision from 1.3% to
9.4% in Medline and from 5% to 28% in EMBASE.31
The African search ﬁlter comprises names of each
country in Africa, and truncated terms to capture
studies indexed using regional, instead of country-
speciﬁc, names. While the names of the countries in
the ﬁlter are primarily in English, names in the rele-
vant ofﬁcial language for each country (if different
from the English version) were also included.
Similarly, for countries that have changed names over
time, both names were included.31
2. Trial register and Directory of Open-Access repository
websites including http://www.ClinicalTrials.gov,
http://www.who.int/trialsearch/ and http://www.
opendoar.org, respectively, will be searched. In add-
ition, Web of Science Conference Proceedings and
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WorldCat Dissertations and theses will be searched to
identify the grey literature. Extra evidence will be
identiﬁed from the reference lists of included arti-
cles. Experts in Africa will be contacted to help in
identifying other potential sources of information, if
required.
The search strategy was developed and pilot-tested fol-
lowing instructions in the Cochrane handbook for sys-
tematic reviews of interventions,32 and the Centre for
Reviews and Dissemination’s guidance for undertaking
reviews in healthcare.33 The search strategy was subse-
quently critically evaluated, piloted and edited in con-
sultation with the two health information specialists. See
the online supplementary appendix for detailed search
strategy for all the global databases. This search strategy
will be adapted for the African regional databases.
Study records
Data management
Literature search results will be imported into Endnote
software for deduplication of records. The deduplicated
records will be uploaded to Eppi-Reviewer, an internet
based software programme to facilitate collaboration
among the reviewers during the process of study selec-
tion. The review team will develop and test screening
questions and forms for the ﬁrst and second levels of
assessment based on the eligibility criteria. Abstracts, full
texts of articles and the screening questions will be
uploaded to Eppi-Reviewer. The screening questions will
be piloted and reﬁned by the review team prior to the
screening exercise.
Selection process
Screening will be performed in two stages: initial screen-
ing of titles and abstracts using the inclusion and exclu-
sion criteria to identify potentially relevant articles will
be carried out by reviewer 1. Initial screening results will
be independently cross-checked by reviewer 2. Initial
screening of titles and abstracts will be followed by
screening of full articles of these papers by reviewer
1. This will be cross-checked by reviewer 2 and disagree-
ments at this stage will be resolved by consensus or con-
sultation with reviewer 3. We will seek additional
information from study authors, if necessary, to resolve
questions about eligibility. The reasons for excluding
studies will be recorded. A ﬂow chart will be used to
trace the overall process.
Appraisal of the quality of included studies
The quality of all included studies will be assessed using
the Mixed Methods Appraisal Tool (MMAT).34 The
MMAT was developed for systematic reviews that include
qualitative, quantitative and mixed methods studies,
allowing the simultaneous appraisal of the quality of the
most common types of empirical studies including
mixed methods primary studies.34 Additionally, the
MMAT has been pilot-tested for content validity,
efﬁciency and reliability.35 For the intervention studies,
the following will be assessed: appropriateness of the
study design to the research objective, risk of bias in
included studies, choice of outcome measures, statistical
issues, quality of reporting, quality of the intervention
and generalisability of the study results. The risk of bias
in included studies will be assessed using the Cochrane
Collaboration’s risk of bias tool including sequence gen-
eration, allocation concealment, blinding, completeness
of outcome data, possibility of selective outcome report-
ing and other potential threats to validity.36
Data collection process
Reviewer 1 will extract the data and these will be con-
ﬁrmed independently by reviewer 2. Inconsistencies will
be resolved by consultation with reviewer 3. Quantitative
data will be extracted from the quantitative studies using
an adaptation of the Cochrane Consumers and
Communication Review Group’s Data Extraction
Template for Cochrane Reviews.37 Qualitative data will
be extracted from the included studies using an adapta-
tion of the Supplementary Guidance for Inclusion of
Qualitative Research in Cochrane Systematic Reviews of
Interventions.38 Some eligible studies may lack some
relevant data; we plan to contact the corresponding
authors of such studies to request any missing informa-
tion that is relevant to the review (maximum of three
email attempts).
Data items
The variables for which data will be collected include:
the country where the study was conducted, the year of
publication, the journal and language of publication,
context and participants’ characteristics (including age
range, gender composition, inclusion and exclusion cri-
teria), sample size (including where relevant by inter-
vention group), targeted chronic condition and
diagnostic criteria, study design, components of the
intervention, the context within which the intervention
was administered, who delivered the intervention, the
length of the intervention and follow-up, the drop-out
rate, outcome(s) measured (including clinical and psy-
chological outcomes), methods for ascertaining/measur-
ing the outcome(s), funding sources, results and
comments.
Outcomes and prioritisation
The primary outcome will include attendance rate for
the exercise and physical activity-related interventions in
studies with no follow-up period postintervention, or the
rate of exercise adherence and physical activity behav-
iour changes postintervention in studies with a follow-up
period postintervention. Exercise adherence will be
deﬁned by the extent to which a patient acts in accord-
ance with the advised interval, exercise dose and exer-
cise dosing regimen. Physical activity behaviour changes
will be deﬁned by changes in patients’ bodily move-
ments that result in energy expenditure such as daily
routine household, job-related activities or recreational
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activities. Attendance or adherence rate is chosen as the
primary outcome as this may be relevant across diverse
chronic conditions, potentially enabling a meta-analysis.
Additionally, this review seeks to identify factors that
might increase patients’ adherence to exercise and phys-
ical activity-related interventions in Africa. Increased
adherence might then translate into increased effective-
ness of these interventions in Africa. In contrast, some
of the secondary outcomes might be more relevant in
some chronic conditions than in others.
Secondary outcomes will include other clinical out-
comes: disability/physical function, pain, blood pressure,
body mass index and blood sugar, using validated mea-
sures. Psychological health outcomes (self-efﬁcacy,
knowledge, attitudes, quality of life, conﬁdence, self-
esteem, well-being, vitality, social functioning, coping)
will be assessed using validated measures. Outcome deﬁ-
nitions will be based on the deﬁnitions used in the
included studies. For crossover trials, we will extract data
from the ﬁrst period only, because of potential carry-
over effects.
Risk of bias in individual studies
To facilitate the assessment of possible risk of bias for
each intervention study, we will collect information using
the Cochrane collaboration tool for risk of bias assess-
ment including: sequence generation, allocation con-
cealment, blinding, incomplete outcome data
(drop-outs and withdrawals) and selective outcome
reporting (table 8.5a in the Cochrane Handbook for
Systematic Reviews of Interventions).32 The procedures
undertaken to assess each domain for each study will be
explicitly described and rated as ‘high risk’ or ‘low risk’.
The risk of bias in a study will be reported as unclear if
there were insufﬁcient details in the original study. In
such instances, the study investigators will be contacted
to provide the required details. The judgements for the
risk of bias will be made independently by reviewer 1
and 2, based on the criteria for judging the risk of bias
(table 8.5c in the Cochrane Handbook for Systematic
Reviews of Interventions).32 Disagreements between
reviewer 1 and 2 will be resolved by consultation of
reviewer 3. We will consider each item in the risk of bias
assessment independently, without assigning an overall
score, to provide the overall strength of evidence.
Appraisal of the quality of the included studies will be
performed after study selection during data extraction
and synthesis, and the strength of evidence for the ﬁnd-
ings of this review will be reported.
Data synthesis and analysis, including assessment of
heterogeneity
Data will be synthesised in two phases using a mixed
studies synthesis design—the sequential explanatory syn-
thesis34—to answer the research questions.
Phase 1 will be used to answer the ﬁrst research ques-
tion: “What is the effectiveness of exercise and physical
activity-related behaviour-change interventions for
managing common chronic non-communicable diseases
in Africa?” In phase 1, the quantitative results of clinical
trials and controlled observational studies, and the quan-
titative results of mixed methods clinical trials and con-
trolled observational studies that assessed the
effectiveness of these interventions, will be tabulated,
compared and pooled in evidence tables. Effectiveness
of exercise and physical activity-related behaviour
change interventions in Africa will be determined by
assessing the presence of differences in effects calcu-
lated statistically using a meta-analysis.34 Narrative syn-
thesis will be used for the data from these quantitative
studies that cannot be analysed statistically.
Phase 2 will be used to answer the second research
question: “What are the experiences and perspectives of
adult African patients on exercise and physical
activity-related behaviour-change interventions for man-
aging common chronic non-communicable diseases?” In
phase 2, the results of the qualitative studies and the
qualitative results of mixed methods studies will be inte-
grated using qualitative thematic analysis. Additionally,
patients’ perspectives and experiences of the exercise
and physical activity-related interventions will be
obtained qualitatively from the uncontrolled observa-
tional studies using taxonomy of the study results.34 The
obtained qualitative data will be analysed thematically
together with the results from the qualitative studies.
Interpretation of the phase 2 results will be used to
determine the useful as well as the unhelpful aspects of
the interventions from the patients’ perspectives.
Finally, interpretation of phase 1 and phase 2 results
will be performed34 to answer the overall objective of
the systematic review: “What are the effective compo-
nents of exercise and physical activity-related
behaviour-change interventions for managing common
chronic non-communicable diseases in adult Africans.”
The effective components of the interventions will be
ascertained by comparing the effectiveness of the inter-
ventions that contained the previously identiﬁed useful
components identiﬁed qualitatively from the qualitative
studies and uncontrolled observational studies, with the
interventions that did not contain these components of
the interventions.
Two tables of characteristics will be designed for
included studies and sorted by the year of publication.39
One of the tables will be for the clinical trials and con-
trolled observational studies, and the other table will be
for the qualitative and uncontrolled observational
studies.
The table for the clinical trials and controlled observa-
tional studies will detail authors’ references, country,
study designs, chronic condition, sample size, gender,
age range, socioeconomic status, outcomes measured,
scales of measurement, objectives of the intervention,
components of the intervention, control arm content,
format and provider of intervention, setting (rural vs
urban), duration of intervention and duration of
follow-up and outcomes.40
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The table for the qualitative and uncontrolled observa-
tional studies will include the authors’ references,
country, study designs, chronic condition, sample size,
gender, age range, socioeconomic status, study objec-
tives, setting (rural vs urban), data collection format,
outcomes or themes.39 40
Statistical analysis
For our statistical analysis of the clinical trials and con-
trolled observational studies, the primary outcome will
include attendance or adherence rate to the exercise
and physical activity-related interventions. Secondary
outcomes will include other clinical outcomes: disabil-
ity/physical function and pain, and change in blood
pressure, body mass index and blood sugar, using vali-
dated measures. Psychological health outcomes (self-
efﬁcacy, knowledge, attitudes, quality of life, conﬁdence,
self-esteem, well-being, vitality, social functioning,
coping) will be assessed using validated measures.
Outcome deﬁnitions will be based on the deﬁnitions
used in the included studies. For crossover trials, we will
extract data from the ﬁrst period only, because of poten-
tial carry-over effects. Results will be pooled for
meta-analysis for homogenous studies with similar
characteristics in terms of design and comparator using
a random effects model. Narrative synthesis will be used
for the rest of the data to explore the relationship and
ﬁndings within and between the included studies, in
line with the guidance from the Centre for Reviews and
Dissemination.33 Results will be presented in order of
primary outcomes followed by additional outcomes.
The statistical strategy will involve ﬁnding the absolute
change in means from the baseline (and the 95% CIs)
in the intervention and control groups where baseline
data are available. Relative percentage change between
postintervention values in the intervention and control
groups will be used where baseline data are not
reported. The risk of the outcome in the intervention
group will be compared with the control group, with a
risk difference calculated from the absolute difference
between the treatment and control groups, or the rela-
tive risk (or equivalents) for outcome measures that are
dichotomous. A record of all adverse effects such as
death or worse clinical effects will be documented.
Treatment effects will be assessed where possible using
risk ratio (RR) with 95% CI, as RR is more intuitive than
OR. Furthermore, clinicians often interpret OR as RR
leading to overestimation of effects. Weighted mean dif-
ferences with 95% CIs will be used for continuous out-
comes. Standardised mean differences at 95% CIs will
be used if different measurement scales are used.
Skewed data and non-quantitative data will be reported
descriptively.
Clinical, methodological and statistical heterogeneity
might be signiﬁcant because of diverse conditions, popu-
lations and interventions, and study designs, methods
and outcomes, respectively. Heterogeneity will be
assessed through the Cochran’s χ2 test, based on a 10%
level of signiﬁcance cut-off. Heterogeneity will further
be quantiﬁed with the use of I2 for which values of 25%,
50% and 75% indicate, respectively, low, medium and
high heterogeneity.41 Data analysis will use SATA V.12
statistical software and R statistical software
(V.3.0.32014-03-04, the R Foundation for Statistical
Computing, Vienna, Austria).
Sensitivity analysis
Subgroup analyses will be used to determine the inﬂu-
ence of gender, disease condition and rural versus
urban habitation on the results.
Meta-biases
Data from studies published only as abstracts will be
added to the meta-analyses to determine if these inﬂu-
enced results. If possible, an investigation of the impact
of publication bias will be made via funnel plots and
Egger test.42
Qualitative data analysis
For qualitative data analysis of the qualitative studies,
mixed methods studies and non-controlled observational
studies, thematic synthesis43 will be used to synthesise
the qualitative data following these steps:
1. Free line-by-line coding of the ﬁndings of primary
qualitative studies or qualitative results of mixed
methods studies. We will code non-controlled obser-
vational studies using a qualitative hybrid
deductive-inductive analysis with concept mapping.34
Study ﬁndings will be taken as all of the text labelled
as results or ﬁndings. The non-quantitative data in
the entire results section of the included studies will
be coded.
2. Organisation of free codes into related areas to con-
struct descriptive themes.
3. Development of analytical themes from the interpret-
ation and abstraction of the descriptive themes into
higher order explanations.
Each of these stages of qualitative analysis will be vali-
dated by the review team by comparing the generated
codes and themes with the results of the primary
studies.
Confidence in cumulative evidence
The quality of evidence of the studies will be assessed to
determine the conﬁdence in cumulative estimates in the
systematic review. This will be judged using the Grading
of Recommendations Assessment, Development and
Evaluation (GRADE) approach.44 The quality of evi-
dence will be assessed across the domains of risk of bias,
consistency, directness, precision and publication bias.
The quality of a study will be rated as high where
further research is unlikely to change the effect esti-
mates, moderate where further research is likely to have
an important impact on the effect estimates or change
the estimate, low where further research is very likely to
have an important impact on the effect estimates and
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change the estimate or very low where the estimate of
effects is very uncertain.
Reporting of this review
The current systematic review will be reported following
the Preferred Reporting Items for Systematic reviews
and Meta-Analyses (PRISMA) Statement.45 Where rele-
vant, reporting will be adapted to make sure that all
items relevant to the review are included in the report.
A PRISMA checklist will be published with the ﬁnal
report.
Potential amendments
We do not intend to make amendments to the quantita-
tive aspects of this systematic mixed studies review proto-
col based on the ﬁndings from the included studies, to
avoid the introduction of outcome reporting bias. This
is because quantitative studies are more easily inﬂuenced
by publication bias and the manifestations of these
biases are more easily assessed. Any unforeseen amend-
ments will not be inﬂuenced by the results of the
included studies, and will be approved by the authors of
this protocol. Documentation and implementation of
probable amendments will be carried out by the ﬁrst
author.
Ethics and dissemination plans
The current systematic review utilises data from pub-
lished studies, therefore, ethics approval is not a require-
ment. This review is expected to inform the
development of exercise and physical activity-related
behaviour-change interventions in Africa. The results
from this study will be published in peer-review journals
and as a PhD thesis at King’s College London. Findings
will also be presented at conferences and, where pos-
sible, shared with relevant health authorities. We further
plan to update the review over time as appropriate.
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